L-R: Myrobalan Therapeutics' scientific founders Zhigang He and Guoping Feng and co-founder and CEO Jing Wang
January 10, 2024 06:45 AM ESTUpdated 11:59 AM
Financing
Startups
China

CNS biotech My­robal­an Ther­a­peu­tics rais­es $24M Se­ries A to en­ter the clin­ic

Kyle LaHucik

Senior Reporter

My­robal­an Ther­a­peu­tics has raised $24 mil­lion to en­ter the clin­ic with one of its four CNS ther­a­peu­tic can­di­dates, with the goal of ei­ther re­pair­ing or …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times